Azeliragon in MGMT Unmethylated Glioblastoma
Azeliragon in MGMT Unmethylated Glioblastoma
Active, not recruiting · NCT05986851 · Registry updated 2026-03-31Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Azeliragon in MGMT Unmethylated Glioblastoma | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, astrocytoma (excluding glioblastoma), epithelial neoplasm, glioblastoma, glioma, neoplasm, neuroepithelial neoplasm, primitive neuroectodermal tumor | Active, not recruiting | Phase 2 | 2026-03-31 | NCT05986851 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Cantex Pharmaceuticals | 2 |
| Medpace, Inc. | 17 |
8 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Corewell Health | Royal Oak | United States | 6 |
| Lenox Hill Hospital | New York | United States | 6 |
| Miami Cancer Institute - Baptist Health | Miami | United States | 1 |
| The University of Oklahoma Health Science Center | Oklahoma City | United States | 1 |
| University of Colorado Anschutz Medical Campus | Aurora | United States | 142 |
| University of Utah Health Huntsman Cancer Center | Salt Lake City | United States | 1 |
| University of Washington | Seattle | United States | 36 |
| Washington University in St. Louis | St Louis | United States | 79 |